Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — FY2021 Earnings Presentation
17 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Mar 3, 2022
Slide 1: Analyst Conference
Analyst Conference Drägerwerk AG & Co. KGaA March 3, 2022, Lübeck
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Dräger: Highlights 2021, Financials 2021, Outlook 2022
Dräger Highlights 2021 Financials 2021 Outlook 2022 3
Slide 4: Overview 2021
Overview 2021 Stronger Net Sales and EBIT than anticipated Core markets in Safety are starting to recover. Remaining high uncertainty for global economy due to continuing pandemic and geopolitical tensions. Net sales distribution in 2021 well balanced. High risiks of disruptions in the global supply
Slide 5: Innovations Medical Safety
Innovations Medical Individual work- Safety place design PSS AirBoss – new generation of firefighters Health promoting atmosphere breathing apparatus − Increased visibility through reflective surfaces and buddy lights User-friendly − Various sensors improve the situational awareness of the Ergonomic
Slide 6: Financials Fiscal Year 2021
FINANCIALS Fiscal Year 2021
Slide 7: Dräger Group Financial performance
Dräger Group Financial performance Net Sales (in EUR million) EBIT (in EUR million) Highlights − Demand for COVID-19 relevant products -1.8% 11.6% 8.2% lasted longer than originally expected. FX adjusted Margin Margin − Orders on hand above the level at the end -2.3% of 2019 (pre-Corona). Good order
Slide 8: Dräger Group Key Figures
Dräger Group Key Figures 12M 2021 12M 2020 Change € million € million % Cashflow from operating activities 384.9 460.0 -16.3 Investments 194.3 178.0 9.1 Cash and cash equivalents1 445.7 497.3 -10.4 Net financial debt1 -24.0 187.1 >-100 Net financial debt 1 /EBITDA 2 -0.06 0.36 Capital employed 1 1,3
Slide 9: Medical division Financial performance
Medical division Financial performance Order Entry Net Sales EBIT -22.6% -9.7% -41.8% FX adjusted FX adjusted 14.3% -23.3% -10.3% EBIT- 9.3% margin EBIT- Nominal Nominal margin 2,498 329.4 1,917 2,302 2,064 191.6 2020 2021 2020 2021 2020 2021 Comments Q4 FY Order − Demand for COVID-19 relevant produ
Slide 10: Safety division Financial performance
Safety division Financial performance Order Entry Net Sales EBIT -8.8% +14.5% +19.1% FX adjusted FX adjusted 6.3% 6.1% EBIT- -9.1% +14.5% 1,288 Nominal 1,171 Nominal 1,264 EBIT- margin 1,104 margin 80.0 64.4 2020 2021 2020 2021 2020 2021 Comments Q4 FY Order − Recovery of demand in many product area
Slide 11: Simplification of the capital structure (1 of 2)
Simplification of the capital structure Termination of participation certificates (1 of 2) Distributable result 32% 100% Participation certificates Common & preferred shares Series A, series K, series D 5 Securities 2 Securities 68% Common & preferred shares 11
Slide 12: Simplification of the capital structure (2 of 2)
Simplification of the capital structure Termination of participation certificates (2 of 2) Termination of participation certificates Earnings per share In 2020, all 831,951 outstanding participation certificates were cancelled Pro forma as of December 2020, assuming full distribution and including d
Slide 13: Outlook Fiscal Year 2022
OUTLOOK Fiscal Year 2022
Slide 14: Dividend proposal for FY 2021
Dividend proposal for FY 2021 2020 (in EUR million) 2021 (in EUR million) Net profit* 250.2 154.2 Dividend 4.5 3.7 Participation certificates** 1.6 0.7 Common shares 1.3 1.3 Preferred shares 1.4 1.6 Net payout ratio 1.8% 2.4% Dividend per common share preferred share Dividend policy Until the
Slide 15: Outlook FY 2022
Outlook FY 2022 2021 guidance1 2021 2022e Net Sales growth -7.0 % – 11.0 % -1.8 % -5.0 to -9.0 % (net of currency effects) EBIT margin 5.0 % – 8.0 % 8.2 % 1.0 to 4.0 %2 Gross profit margin Prior year’s level 46.3 % 44.0 to 46.0 % (47.2%) +/-1 pp Dräger Value Added EUR 44m to 142m EUR 171.8m EUR -70
Slide 16: Questions & Answers
Questions & Answers Drager — “ Drager. Technology for Life®
Slide 17: Dräger. Technology for Life
Drager. Technology for Life®
Drägerwerk AG & Co. KGaA — FY2021 Earnings Presentation on 6ix